Now, even though it is simple to laugh within the ridiculousness of this patent, undesirable patents have severe implications for the entire psychedelics sector.“NeonMind’s proprietary preclinical information reveals promise that both equally minimal and higher dose psilocybin may lessen bodyweight gain and that the reduction in excess weight g